NEW YORK STOCK EXCHANGE, INC. · ZTS
+2.49% · +$1.93
Zoetis Inc

Zoetis Inc

Pharmaceuticals
$79.52

Veridion Score

Loading
Score loading…
Veridion Score History · 90D

Composite trend over time

LOADING HISTORY…
REFRESHES DAILY
AI Analysis
BETA

Why is ZTS moving today?

Analyzing news articles + insider activity + analyst signals…
About Zoetis Inc
PHARMACEUTICAL PREPARATIONS
Founded
Listed
2013
Employees
15K
HQ
US

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Open
$79.37
Previous close
$77.59
Day high
$81.63
Day low
$78.64
Market cap
$32.57B
IPO
2013-02-01
Country
US
Currency
USD
Data ledger
Quote and day range
As of June 4, 4:00 PM EDT
Source: Market data
Veridion Score
Coverage building
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Loading quarterly statements…
SEC Form 4 ledger

ZTS insider activity

Zoetis Inc

Score
Coverage building
Pressure
Net selling
Filings
77
Buys / sells
38 / 39
Net value
-$2.1M
Insiders
21
Named filers
BP
Bisaro Paul
Insider
Leadership
DA
DAMELIO FRANK A
Insider
Leadership
MB
MCCALLISTER MICHAEL B
Insider
Leadership
Cluster

12 insiders bought in the last 90 days

Net pressure

Net selling: -$2.1M across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing dateTrade dateInsiderTitleTypePriceQtyOwnedValueReceipt
2026-05-132026-05-13Bisaro PaulInsiderbuy$75.882,00027,862$152KSEC Form 4
2026-05-132026-05-13DAMELIO FRANK AInsiderbuy$75.396,65021,458$501KSEC Form 4
2026-05-122026-05-11MCCALLISTER MICHAEL BInsiderbuy$77.763,00024,524$233KSEC Form 4
2026-05-012026-04-30Esch KevinInsidersell$114.9775578$9KSEC Form 4
2026-04-132026-04-10FULLER JULIEInsiderbuy$39.645511,798$22KSEC Form 4
Full Form 4 history requires Sovereign

Showing 5 recent rows. Sovereign unlocks 72 additional rows, full sorting, and the named-filer history.

Upgrade to Sovereign · $25/mo
Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Loading PTR filings…
Federal contracts

ZTS contract awards, year to date.

Public federal awards linked to this ticker.

$1.2M
Refresh interval: 12hSource: Federal contract awards
Department of Agriculture
$626.9K
MYCOBACTERIUM BOVIS PURIFIED PROTEIN DERIVATIVE (PPD) TUBERCULIN

MYCOBACTERIUM BOVIS PURIFIED PROTEIN DERIVATIVE (PPD) TUBERCULIN

Apr 28, 2026
Department of Agriculture
$484.5K
PHARMACEUTICALS AND PESTICIDES

PHARMACEUTICALS AND PESTICIDES

May 10, 2026
Department of Agriculture
$99.7K
FIRM-FIXED PRICE PURCHASE ORDER TO OBTAIN BM86 IMMUNOMODULATOR 10DS 20ML VIALS OF INJECTABLE VACCINE FOR THE TREATMENT OF CATTLE FEVER TICKS ON WILDLIFE UNDER THE AUSPICES OF THE USDA CATTLE FEVER TICK ERADICATION PROGRAM (CFTEP) IN TEXAS.

FIRM-FIXED PRICE PURCHASE ORDER TO OBTAIN BM86 IMMUNOMODULATOR 10DS 20ML VIALS OF INJ...

Apr 20, 2026
Lobbying spend

ZTS lobbying filings, year to date.

Registered lobbying filings matched to Zoetis Inc.

$560.0K
Refresh interval: 12hSource: LDA disclosure filings
AgricultureAgriculture Trade (domestic/foreign) Taxation/Internal Revenue Code Government IssuesHealth Issues Taxation/Internal Revenue Code Agriculture Trade (domestic/foreign)
Filing
$180.0K
ZOETIS INC.

ZOETIS INC.

Apr 20, 2026
Filing
$140.0K
ZOETIS INC.

ZOETIS INC.

Jan 20, 2026
Filing
$80.0K
ZOETIS

WILLIAMS AND JENSEN, PLLC

Apr 20, 2026
Latest news · ZTS
Refresh interval: 5 minutes · Source: Market news insights
Loading articles…
Analyst ratings
Loading consensus…
Options · Live
Loading options chain…
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.